Nonreplicating Recombinant Vaccinia Virus Encoding Human B-7 Molecules Elicits Effective Costimulation of Naive and Memory CD4+T Lymphocytesin Vitro
- 1 August 1997
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 179 (2) , 146-152
- https://doi.org/10.1006/cimm.1997.1158
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Heterogeneous effects of B7‐1 and B7‐2 in the induction of both protective and therapeutic anti‐tumor immunity against different mouse tumorsEuropean Journal of Immunology, 1996
- B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 1995
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2Immunity, 1994
- CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clonesNature, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Human cytotoxic T cell responses to vaccinia virus vaccinationJournal of General Virology, 1991
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Structure of vaccinia virus early promotersJournal of Molecular Biology, 1989
- Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune responseEuropean Journal of Immunology, 1986